Infect Chemother.  2019 Sep;51(3):330-335. 10.3947/ic.2019.51.3.330.

Management of Typhoid Fever – Clinical and Historical Perspectives in Korea

Affiliations
  • 1Department of Pathology, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. thanks1126@hanmail.net
  • 3Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

Abstract

Typhoid fever, showed a dramatic decrease in its incidence from 56 per 100,000 population just after Korea's independence to <1 per 100,000 population in 2000s. The clinical features of patients with typhoid fever in Korea were not too different from those reported in textbooks. Beyond cultures and Widal test, other diagnostic techniques such as string capsule culture and polymerase chain reaction have been tried in Korea. As chloramphenicol is not used anymore in Korea, ampicillin, cotrimoxazole, fluoroquinolones, and third-generation cephalosporins have been administered for therapy of typhoid fever. Especially, ciprofloxacin and ceftriaxone were successfully tried with shorter duration of treatment (1 week). However, cases of treatment failure and resistance in ciprofloxacin were reported in Korea, which requires a great caution. As preventive vaccines, parenteral Vi polysaccharide vaccine and oral live attenuated vaccine are mainly used in Korea. The decline in the number of chronic carriers of typhoid fever in Korea by the roles of doctors and patient management from the health care authorities such as Korea Centers for Diseases Control and Prevention, prescription of effective antimicrobial agents, and increased piped water supply ratio are considered to be the major contributing factors to the reduction in the outbreak of typhoid fever in Korea.

Keyword

Typhoid fever; Epidemiology; Management; Prevention

MeSH Terms

Ampicillin
Anti-Infective Agents
Ceftriaxone
Cephalosporins
Chloramphenicol
Ciprofloxacin
Delivery of Health Care
Epidemiology
Fluoroquinolones
Humans
Incidence
Korea
Polymerase Chain Reaction
Prescriptions
Treatment Failure
Trimethoprim, Sulfamethoxazole Drug Combination
Typhoid Fever*
Vaccines
Water Supply
Ampicillin
Anti-Infective Agents
Ceftriaxone
Cephalosporins
Chloramphenicol
Ciprofloxacin
Fluoroquinolones
Trimethoprim, Sulfamethoxazole Drug Combination
Vaccines

Reference

1. The Korean Society of Infectious Diseases. History of infectious disease in Korea: Chapter 7. Japanese colonial era - Typhoid Fever. Seoul: Koonja;2009. p. 434–437.
2. Korea Centers for Disease Control and Prevention (KCDC). 2016 infectious diseases surveillance yearbook. Osong: KCDC;2017.
3. Korea Centers for Disease Control and Prevention (KCDC). Guidelines for infectious disease control operation. Osong: KCDC;2011.
4. Kim YG, Joung TW, Song C, Lee MW, Kim JS, Oh DK. A study on the status of reporting typhoid fever cases admitted. Korean J Epidemiol. 1985; 7:240–252.
5. Chun CH. Brief history of infectious diseases in Korea. Korean J Infect Dis. 1969; 1:72–78.
6. Chung HY. Enteric bacterial infection. Korean J Infect Dis. 1969; 1:19–26.
7. Kim WJ, Park SC. Typhoid fever. J Korean Med Assoc. 1992; 35:863–869.
8. Kim JP, Oh SK, Jarrett F. Management of ileal perforation due to typhoid fever. Ann Surg. 1975; 181:88–91.
Article
9. Song JH. Development of a novel diagnostic method of typhoid fever using polymerase chain reaction. Korean J Med. 1994; 46:229–237.
10. Oh IH. Treatment of typhoid fever. Korean J Infect Dis. 1969; 1:14–18.
11. Kim YJ, Chun HJ, Lee JW, Hong KW, Kim SI, Wie SH, Kim YR, Kang MW. The changing patterns of antibiotics usage in Korea during 1981-2008. Infect Chemother. 2012; 44:411–418.
Article
12. Choe KW, Kim SM, Oh MD. Ciprofloxacin therapy in typhoid fever. J Korean Soc Chemother. 1990; 8:105–110.
13. Kim DB, Kim SH, Oh SJ, Kim DK, Choi SM, Kim M, Shin WS. Three cases of ciprofloxacin treatment failure in imported typhoid fever. Korean J Med. 2009; 77:377–381.
14. Woo J. Typhoid fever, cholera vaccine. Korean J Med. 1996; 51:Suppl 2. 77–82.
15. Hwang C. The amendment tendency analysis of the Korean infectious disease prevention act and a recommendation for the next amendment. Yonsei University Graduate School of Public Health;1998.
16. Chun BC. Public policy and laws on infectious disease control in Korea: past, present, and prospective. Infect Chemother. 2011; 43:474–484.
Article
17. Inha University College of Medicine, Korea Centers for Disease Control and Prevention. Establishment of strategies improving the efficiency of typhoid carriers search operation. 2008.
18. Ministry of Environment. 2015 water supply statistics. Accessed August 13, 2019. Available at: http://www.me.go.kr/home/web/policy_data/read.do?menuId=10264&seq=6898.
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr